MRD / Regn No. : 6258 Date : 01/07/2026
Patient Name : Zaheda Baby Age & Gender : 56 Yrs. / Female
Contact No. : 8276095793 UHID :
Ht / Wt / BMI : 144 / 64 / 30.86 BP S / BP D : 118 / 71
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (14/Nov/2011) | HYPERTENSION (14/Nov/2022) | DISTAL SENSORY NEUROPATHY (14/Nov/2022) | MASLD (11/Feb/2025) | ANEMIA MICROCYTIC HYPOCHORMIC (11/Feb/2025) |
Salient Investigations : TGL TRIGLYCERIDE: 80 mg/dL | CREATININE: 0.6 | EGFR EGLOMERULAR FILTRATION RATE: 110.76 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.4 % | LDL LOW DENSITY LIPOPROTEIN: 77 mg/dL | LIVER CAP SCORE: 265 dB/M | LIVER TE SCORE: 21.8 kPA
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN 80 MG + AMLODIPINE 5 MG
TELDAY AM 80/5 MG
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
2 ANTILIPIDEMIC ATORVASTATIN 40 MG
TONACT 40 MG
PO 0-0-1 BEFORE FOOD
TILL NEXT VISIT
3 GLICLAZIDE 80 MG + METFORMIN 500 MG
GLIZID M
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
4 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
5 SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC
SC ONCE A WEEK AFTER BREAKFAST
4 WEEKS
6 ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG
SC ONCE A WEEK AFTER BREAKFAST
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 01/Jan/2027
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,LIPID PROFILE,CREATININE,FIBROSCAN (CAP & LSM SCORES)
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: